A critical breakthrough in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This essential cancer suppressor protein is frequently disabled in many types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research